Actavis Expands in Women’s Health with Uteron Pharma Purchase
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 2 (Table of Contents)
Published: 7 Feb-2013
DOI: 10.3833/pdr.v2013.i2.1893 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Watson Pharmaceuticals, now officially known as Actavis, has acquired the Belgium-based women’s healthcare company Uteron Pharma in a deal worth up to US$305 M in order to expand its late-stage branded product pipeline...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS